THEME: "Empowering Hearts, Empowering Lives: Shaping the Future of Cardiovascular Health"
15-16 Mar 2027
London, UK Dedicated to pulmonary hypertension, right ventricular failure, and pulmonary circulation dynamics.
Sub-topics:
Activin signaling inhibitors (e.g., Sotatercept) and novel pathways in Pulmonary Arterial Hypertension (PAH)
Right ventricular-pulmonary arterial (RV-PA) coupling evaluation using echocardiography and CMR
Surgical and interventional treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH/CTEPD)